IRIDEX Corporation (IRIX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, IRIDEX Corporation (IRIX) has a cash flow conversion efficiency ratio of -0.247x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.16 Million) by net assets ($4.68 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
IRIDEX Corporation - Cash Flow Conversion Efficiency Trend (1995–2024)
This chart illustrates how IRIDEX Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read IRIDEX Corporation debt and liabilities for a breakdown of total debt and financial obligations.
IRIDEX Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of IRIDEX Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Melati Ehsan Holdings Bhd
KLSE:5129
|
0.055x |
|
Creative Media & Community Trust Corporation
NASDAQ:CMCT
|
0.012x |
|
Intraco Penta Tbk
JK:INTA
|
-0.008x |
|
Ceres Power Holdings PLC
LSE:CWR
|
0.024x |
|
Nafpaktos Textile Industry S.A
AT:NAYP
|
0.024x |
|
Garanti Yatirim Ortakligi AS
IS:GRNYO
|
0.026x |
|
Andalan Sakti Primaindo PT
JK:ASPI
|
-0.124x |
|
Linkers Industries Limited Class A Ordinary Shares
NASDAQ:LNKS
|
N/A |
Annual Cash Flow Conversion Efficiency for IRIDEX Corporation (1995–2024)
The table below shows the annual cash flow conversion efficiency of IRIDEX Corporation from 1995 to 2024. For the full company profile with market capitalisation and key ratios, see IRIX market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $2.10 Million | $-7.29 Million | -3.474x | -390.43% |
| 2023-12-31 | $9.52 Million | $-6.75 Million | -0.708x | -28.23% |
| 2022-12-31 | $17.23 Million | $-9.52 Million | -0.552x | -256.64% |
| 2021-12-31 | $23.30 Million | $8.22 Million | 0.353x | +289.21% |
| 2020-12-31 | $17.37 Million | $-3.24 Million | -0.186x | +46.52% |
| 2019-12-31 | $22.70 Million | $-7.91 Million | -0.349x | -4.16% |
| 2018-12-31 | $29.96 Million | $-10.03 Million | -0.335x | -186.47% |
| 2017-12-31 | $30.52 Million | $-3.56 Million | -0.117x | -3076.34% |
| 2016-12-31 | $39.16 Million | $-144.00K | -0.004x | +79.11% |
| 2015-12-31 | $33.69 Million | $-593.00K | -0.018x | -114.79% |
| 2014-12-31 | $33.74 Million | $4.01 Million | 0.119x | +301.07% |
| 2013-12-31 | $25.85 Million | $767.00K | 0.030x | +246.69% |
| 2012-12-31 | $21.91 Million | $-443.00K | -0.020x | -114.88% |
| 2011-12-31 | $22.43 Million | $3.05 Million | 0.136x | -24.10% |
| 2010-12-31 | $19.43 Million | $3.48 Million | 0.179x | -60.42% |
| 2009-12-31 | $15.03 Million | $6.80 Million | 0.452x | +5635.50% |
| 2008-12-31 | $11.75 Million | $-96.00K | -0.008x | +70.55% |
| 2007-12-31 | $18.81 Million | $-522.00K | -0.028x | +35.57% |
| 2006-12-31 | $32.16 Million | $-1.39 Million | -0.043x | -153.67% |
| 2005-12-31 | $34.52 Million | $2.77 Million | 0.080x | +230.82% |
| 2004-12-31 | $31.78 Million | $771.00K | 0.024x | -85.34% |
| 2003-12-31 | $30.83 Million | $5.10 Million | 0.165x | +98.40% |
| 2002-12-31 | $30.20 Million | $2.52 Million | 0.083x | +168.46% |
| 2001-12-31 | $29.83 Million | $-3.63 Million | -0.122x | -4921.99% |
| 2000-12-31 | $30.50 Million | $-74.00K | -0.002x | -102.33% |
| 1999-12-31 | $27.50 Million | $2.86 Million | 0.104x | +234.75% |
| 1998-12-31 | $25.90 Million | $-2.00 Million | -0.077x | -1745.56% |
| 1997-12-31 | $23.90 Million | $-100.00K | -0.004x | +93.08% |
| 1996-12-31 | $21.50 Million | $-1.30 Million | -0.060x | -131.58% |
| 1995-12-31 | $4.70 Million | $900.00K | 0.191x | -- |
About IRIDEX Corporation
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and Oc… Read more